SCHEMBL3201229

SCHEMBL3201229

CCOc1cc(N(Cc2cnco2)c2ccc(C(=O)OC(C)(C)C)cc2)ccc1OC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.38
GPR119 Q8TDV5 1/20 0.38
HRH4 Q9H3N8 1/20 0.38
HPGD P15428 2/20 0.37
AAK1 Q2M2I8 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPK1 P28482 1/20 0.37
NAMPT P43490 1/20 0.36
IMPDH2 P12268 2/20 0.35
IMPDH1 P20839 2/20 0.35
TSHR P16473 1/20 0.35
PDE4A P27815 3/20 0.35
PDE4B Q07343 3/20 0.35
PDE4C Q08493 3/20 0.35
PDE4D Q08499 3/20 0.35
L3MBTL1 Q9Y468 3/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3215544 0.96 TSHR (0.40) TP53GPR119HRH4HPGDAAK1
SCHEMBL3192199 0.95 HRH4 (0.39) GPR119HRH4HPGDAAK1ALDH1A1
SCHEMBL3123133 0.92 SREBF1 (0.37) TP53GPR119HRH4HPGDAAK1
SCHEMBL3126123 0.90 HRH4 (0.38) GPR119HRH4AAK1MAPK1NAMPT
SCHEMBL3201953 0.89 GPR119 (0.41) GPR119PDE4APDE4BPDE4CPDE4D
SCHEMBL3129701 0.89 SREBF1 (0.40) GPR119HRH4HPGDAAK1ALDH1A1
SCHEMBL3202834 0.89 RXRA (0.40) GPR119HRH4AAK1ALDH1A1MAPK1
SCHEMBL3204443 0.89 GPR119 (0.43) GPR119PDE4APDE4BPDE4CPDE4D
SCHEMBL3192278 0.88 AAK1 (0.39) GPR119AAK1ALDH1A1MAPK1NAMPT
SCHEMBL3249961 0.88 GPR119 (0.39) GPR119AAK1NAMPTIMPDH2IMPDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B TP53 4688/4885GPR119 408/4885HRH4 442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.